Impact of SER 109, an Investigational Microbiome Therapeutic on Health-Related Quality of Life in Patients With Recurrent Clostridioides Difficile Infection: Results From ECOSPOR III, a Placebo-Controlled Clinical Trial

被引：0
|
作者：
Brown, Lisa [1 ]
Elizabeth, Hohmann [1 ]
Paul, Feuerstadt [1 ]
Caterina, Oneto [1 ]
Berenson, Charles [1 ]
Christine, Lee [1 ]
Sissi, Pham [1 ]
Ray, Reese Pat [1 ]
Henry, Wu [1 ]
Elaine, Wang [1 ]
Lisa, von Moltke [1 ]
Kevin, Garey [1 ]
机构：
[1] Seres Therapeut, Brooklyn, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2021年 / 46卷 / SUPPL 1期
关键词：
Microbiome; Microbiota-Gut-Brain Axis; Microbiota; Gut-Brain Axis; Fecal Microbiota Transplant;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P334
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [31] The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
    Dirven, Linda
    van den Bent, Martin J.
    Bottomley, Andrew
    van der Meer, Nelly
    van der Holt, Bronno
    Vos, Maaike J.
    Walenkamp, Annemiek M. E.
    Beerepoot, Laurens V.
    Hanse, Monique C. J.
    Reijneveld, Jaap C.
    Otten, Aja
    de Vos, Filip Y. F. L.
    Smits, Marion
    Bromberg, Jacoline E. C.
    Taal, Walter
    Taphoorn, Martin J. B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1321 - 1330
  • [32] Health-related quality of life (HRQOL) and disability in chronic migraine: Results from a randomized, double-blind, placebo-controlled trial of topiramate
    Dodick, David
    Silberstein, Stephen
    Saper, Joel
    Mathew, Ninan
    Hulihan, Joseph
    Crivera, Concetta
    Rupnow, Marcia
    Mao, Lion
    Greenberg, Steven
    NEUROLOGY, 2007, 68 (12) : A370 - A370
  • [33] Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial
    Feldman, SR
    Kimball, AB
    Krueger, GG
    Woolley, JM
    Lalla, D
    Jahreis, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (05) : 887 - 889
  • [34] Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection
    Dubberke, Erik R.
    Orenstein, Robert
    Khanna, Sahil
    Guthmueller, Beth
    Lee, Christine
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (02) : 703 - 709
  • [35] Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection
    Erik R. Dubberke
    Robert Orenstein
    Sahil Khanna
    Beth Guthmueller
    Christine Lee
    Infectious Diseases and Therapy, 2023, 12 : 703 - 709
  • [36] Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial
    Nouri-Vaskeh, Masoud
    Afshan, Hossein
    Mahdavi, Aida Malek
    Alizadeh, Leila
    Fan, Xiude
    Zarei, Mohammad
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49
  • [37] Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial
    Bouleuc, Carole
    Anota, Amelie
    Cornet, Cecile
    Grodard, Ghislain
    Thiery-Vuillemin, Antoine
    Dubroeucq, Olivier
    Cretineau, Nathalie
    Frasie, Veronique
    Gamblin, Vincent
    Chvetzoff, Gisele
    Favier, Laure
    Tournigand, Christophe
    Grach, Marie-Christine
    Raynard, Bruno
    Salas, Sebastien
    Capodano, Geraldine
    Pazart, Lionel
    Aubry, Regis
    ONCOLOGIST, 2020, 25 (05): : E843 - E851
  • [38] Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
    Sanyal, A.
    Younossi, Z. M.
    Bass, N. M.
    Mullen, K. D.
    Poordad, F.
    Brown, R. S.
    Vemuru, R. P.
    Jamal, M. Mazen
    Huang, S.
    Merchant, K.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 853 - 861
  • [39] Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial
    Navarro-Compan, Victoria
    Wei, James Cheng-Chung
    Van den Bosch, Filip
    Magrey, Marina
    Wang, Lisy
    Fleishaker, Dona
    Cappelleri, Joseph C.
    Wang, Cunshan
    Wu, Joseph
    Dina, Oluwaseyi
    Fallon, Lara
    Strand, Vibeke
    RMD OPEN, 2022, 8 (02):
  • [40] Function and health-related quality of life - Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis
    Strand, V
    Tugwell, P
    Bombardier, C
    Maetzel, N
    Crawford, B
    Dorrier, C
    Thompson, A
    Wells, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : 1870 - 1878
12345